In a mouse model of stroke, intracerebroventricular sodium selenate treatment elevates GPX4 levels by activating transcription factors activating enhancer binding protein 2 and specificity protein 1, while also providing protection against excitotoxicity and endoplasmic reticulum stress-induced cell death independent of GPX4 (102)
They may be able to prescribe a covered GLP1 for a different indication, such as diabetes or cardiovascular disease, if you qualify
Hence, incretinbased treatments, particularly GLP1 receptor agonists and dual GIP/GLP1 agents, are being considered for their broader metabolic benefits
Retatrutide Products & Research Compounds | Alluvi Health-Care
Since this manuscript was written, the following authors have changed affiliation: Sharmistha Roy Chowdhury is now affiliated with the University Hospital of Wales, Cardiff and Vale UHB, Cardiff, United Kingdom
It took weeks to feel better